Ovsyannikova Inna G, Schaid Daniel J, Larrabee Beth R, Haralambieva Iana H, Kennedy Richard B, Poland Gregory A
Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, United States of America.
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United States of America.
PLoS One. 2017 Feb 3;12(2):e0171261. doi: 10.1371/journal.pone.0171261. eCollection 2017.
Human antibody response to measles vaccine is highly variable in the population. Host genes contribute to inter-individual antibody response variation. The killer cell immunoglobulin-like receptors (KIR) are recognized to interact with HLA molecules and possibly influence humoral immune response to viral antigens. To expand on and improve our previous work with HLA genes, and to explore the genetic contribution of KIR genes to the inter-individual variability in measles vaccine-induced antibody responses, we performed a large population-based study in 2,506 healthy immunized subjects (ages 11 to 41 years) to identify HLA and KIR associations with measles vaccine-induced neutralizing antibodies. After correcting for the large number of statistical tests of allele effects on measles-specific neutralizing antibody titers, no statistically significant associations were found for either HLA or KIR loci. However, suggestive associations worthy of follow-up in other cohorts include B57:01, DQB106:02, and DRB115:05 alleles. Specifically, the B57:01 allele (1,040 mIU/mL; p = 0.0002) was suggestive of an association with lower measles antibody titer. In contrast, the DQB106:02 (1,349 mIU/mL; p = 0.0004) and DRB115:05 (2,547 mIU/mL; p = 0.0004) alleles were suggestive of an association with higher measles antibodies. Notably, the associations with KIR genotypes were strongly nonsignificant, suggesting that KIR loci in terms of copy number and haplotypes are not likely to play a major role in antibody response to measles vaccination. These findings refine our knowledge of the role of HLA and KIR alleles in measles vaccine-induced immunity.
人群中人类对麻疹疫苗的抗体反应差异很大。宿主基因导致个体间抗体反应存在差异。杀伤细胞免疫球蛋白样受体(KIR)被认为可与HLA分子相互作用,并可能影响对病毒抗原的体液免疫反应。为了拓展和改进我们之前关于HLA基因的研究工作,并探索KIR基因对麻疹疫苗诱导的抗体反应个体间变异性的遗传贡献,我们对2506名健康免疫受试者(年龄在11至41岁之间)进行了一项基于人群的大型研究,以确定HLA和KIR与麻疹疫苗诱导的中和抗体之间的关联。在对大量关于等位基因对麻疹特异性中和抗体滴度影响的统计检验进行校正后,未发现HLA或KIR基因座存在统计学上的显著关联。然而,值得在其他队列中进一步研究的提示性关联包括B57:01、DQB106:02和DRB115:05等位基因。具体而言,B57:01等位基因(1040 mIU/mL;p = 0.0002)提示与较低的麻疹抗体滴度相关。相比之下,DQB106:02(1349 mIU/mL;p = 0.0004)和DRB115:05(2547 mIU/mL;p = 0.0004)等位基因提示与较高的麻疹抗体相关。值得注意的是,与KIR基因型的关联极不显著,这表明KIR基因座在拷贝数和单倍型方面不太可能在麻疹疫苗接种的抗体反应中起主要作用。这些发现完善了我们对HLA和KIR等位基因在麻疹疫苗诱导免疫中作用的认识。